European grant to study use of AI in treatment of rheumatoid arthritis

UMC Utrecht has received a European grant of six million euros for an international study on the use of artificial intelligence as a decision aid in the treatment of patients with difficult-to-treat rheumatoid arthritis. The STRATA-FIT study aims to use AI to develop mathematical models that better recognize patient characteristics. It aims to increase the likelihood that the patient will receive a successful customized treatment.

Rheumatoid arthritis (RA) can be difficult to treat in some patients, and some continue to have symptoms despite advances in treatment with modern anti-rheumatic drugs. In the future, physicians expect much from artificial intelligence in order to arrive at better treatment choices for these patients.

Jaap van Laar is the principal investigator of STRATA-FIT, and Paco Welsing is the study's coordinator. They both work in the Department of Rheumatology and Clinical Immunology at UMC Utrecht.

Read more about the study on the UMC Utrecht website.